Literature DB >> 2125217

Catalytically active monoamine oxidase type A from human liver expressed in Saccharomyces cerevisiae contains covalent FAD.

W Weyler1, C C Titlow, J I Salach.   

Abstract

Monoamine oxidase type A from human liver cDNA was expressed in Saccharomyces cerevisiae. This enzyme's properties with respect to Km and Ki values for kynuramine and amphetamine, respectively, were similar to values for human placental enzyme. As expected, clorgyline inhibited the yeast enzyme at lower concentrations than deprenyl. Interestingly, the FAD cofactor was covalently attached and fluorescence properties of the enzyme bound prosthetic group indicate that it is attached to a cysteine residue, the same linkage observed in other monoamine oxidases. The yield of expressed enzyme is about 15 mg/l of culture with an A600 of 15. It is suggested that covalent flavin attachment proceeds by an autoflavination mechanism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2125217     DOI: 10.1016/s0006-291x(05)80914-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B.

Authors:  Dale E Edmondson; Claudia Binda; Andrea Mattevi
Journal:  Arch Biochem Biophys       Date:  2007-05-30       Impact factor: 4.013

Review 2.  Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases.

Authors:  Dale E Edmondson; Claudia Binda; Jin Wang; Anup K Upadhyay; Andrea Mattevi
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

Review 3.  On the practical aspects of characterising monoamine oxidase inhibition in vitro.

Authors:  Andrew Holt
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

4.  Interactions of D-amphetamine with the active site of monoamine oxidase-A.

Authors:  Rona R Ramsay; Dominic J B Hunter
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.